Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine
Clinical trial NCT07655180 · RECRUITING
Trial details
- NCT number
- NCT07655180
- Sponsor
- Invivyd, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-08
- Primary completion
- 2026-08-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.